Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2RL1 | P55085 | 2/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.35 |
| ▸ | ITGAV | P06756 | 4/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.35 |
| ▸ | BAD | Q92934 | 1/20 | 0.35 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | TSLP | Q969D9 | 2/20 | 0.34 |
| ▸ | CD40 | P25942 | 1/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.33 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.33 |
| ▸ | BECN1 | Q14457 | 4/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | GCGR | P47871 | 2/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18972629 | 0.95 | F2RL1 (0.41) | F2RL1ITGB3ITGAVBCL2L1BAD | |
| SCHEMBL18972613 | 0.85 | F2RL1 (0.47) | F2RL1ITGB3ITGAVBCL2L1BAD | |
| SCHEMBL18972405 | 0.84 | F2RL1 (0.45) | F2RL1ITGB3ITGAVBCL2L1BAD | |
| SCHEMBL18972610 | 0.81 | F2RL1 (0.47) | F2RL1ITGB3ITGAVBCL2L1BAD | |
| SCHEMBL18972398 | 0.79 | F2RL1 (0.46) | F2RL1ITGB3ITGAVBCL2L1BAD | |
| SCHEMBL29311680 | 0.60 | CCKBR (0.49) | KEAP1 | |
| SCHEMBL29311679 | 0.60 | CCKBR (0.49) | KEAP1 | |
| SCHEMBL27274067 | 0.60 | CCKBR (0.48) | KEAP1 | |
| SCHEMBL22962364 | 0.58 | CD40 (0.54) | CD40 | |
| SCHEMBL7738281 | 0.58 | ITGB3 (0.52) | ITGB3ITGAVITGB1ITGA5KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170168041-A1 | Polymers And Oligomers With Aggregation-Induced Emission Characteristics For Imaging And Image-Guided Therapy | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170168041-A1 | Polymers And Oligomers With Aggregation-Induced Emission Characteristics For Imaging And Image-Guided Therapy | MAPT, FUS, CLTB | F2RL1 797/4885ITGB3 1163/4885ITGAV 1637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.